What Is In The Japanese Encephalitis Vaccine

A japanese encephalitis vaccine is available for people aged 12 months and older and is recommended for travellers spending extended one month or more in rural areas of high risk countries for je.

What is in the japanese encephalitis vaccine. Who recommends having strong prevention and control activities including je immunization in all regions where the disease is a recognized public health problem. It is spread through the bite of an infected mosquito. Doses are given either by injection into a muscle or just under the skin. Japanese encephalitis je virus is a single stranded rna virus that belongs to the genus flavivirus and is closely related to west nile and saint louis encephalitis viruses.

It does not spread from person to person. Inactivated vero cell culture derived japanese encephalitis je vaccine manufactured as ixiaro is the only je vaccine licensed and available in the united states. Risk is very low for most travelers. Who should get japanese encephalitis vaccine.

For more detailed je vaccination advice see the australian immunisation handbook and consult with your gp or travel medicine clinic. For most travelers to asia the risk for je is very low but varies based on destination length of travel season and activities. Je vaccine also should be considered for shorter term e g less than 1 month travelers with an increased risk of je based on. It is a mosquito borne flavivirus meaning it is related to dengue yellow fever and west nile viruses.

Japanese encephalitis occurs mainly in many parts of asia and the western pacific particularly in rural areas. The vaccines are more than 90 effective. It is recommended as part of routine immunizations in countries where the disease. Japanese encephalitis vaccine is a vaccine that protects against japanese encephalitis.

This vaccine was approved in march 2009 for use in people aged 17 years and older and in may 2013 for use in children 2 months through 16 years of age. It does not spread from person to person. Transmission je virus is transmitted to humans through the bite of an infected mosquito primarily culex species. It is spread through the bite of an infected mosquito.

Je vaccine is recommended for persons moving to a je endemic country to live longer term e g 1 month or longer travelers and frequent travelers to je endemic areas. Japanese encephalitis je is the most important cause of viral encephalitis in asia. The duration of protection with the vaccine is not clear but its effectiveness appears to decrease over time. Japanese encephalitis je vaccine can prevent japanese encephalitis.

Japanese encephalitis je virus is the leading cause of vaccine preventable encephalitis in asia and the western pacific.